- Home
- EFSH vs ABVC Comparison
EFSH vs ABVC Comparison
Compare EFSH & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSH
- ABVC
- Stock Information
- Founded
- EFSH 1948
- ABVC 2015
- Country
- EFSH United States
- ABVC United States
- Employees
- EFSH N/A
- ABVC N/A
- Industry
- EFSH Professional Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- EFSH Consumer Discretionary
- ABVC Health Care
- Exchange
- EFSH Nasdaq
- ABVC Nasdaq
- Market Cap
- EFSH 5.6M
- ABVC 6.5M
- IPO Year
- EFSH N/A
- ABVC N/A
- Fundamental
- Price
- EFSH $0.25
- ABVC $0.48
- Analyst Decision
- EFSH
- ABVC
- Analyst Count
- EFSH 0
- ABVC 0
- Target Price
- EFSH N/A
- ABVC N/A
- AVG Volume (30 Days)
- EFSH 2.6M
- ABVC 361.4K
- Earning Date
- EFSH 11-19-2024
- ABVC 11-14-2024
- Dividend Yield
- EFSH N/A
- ABVC N/A
- EPS Growth
- EFSH N/A
- ABVC N/A
- EPS
- EFSH N/A
- ABVC N/A
- Revenue
- EFSH $69,415,140.00
- ABVC $509,788.00
- Revenue This Year
- EFSH N/A
- ABVC N/A
- Revenue Next Year
- EFSH N/A
- ABVC N/A
- P/E Ratio
- EFSH N/A
- ABVC N/A
- Revenue Growth
- EFSH 228.22
- ABVC N/A
- 52 Week Low
- EFSH $0.20
- ABVC $0.41
- 52 Week High
- EFSH $1,037.40
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- EFSH 39.48
- ABVC 36.66
- Support Level
- EFSH $0.21
- ABVC $0.47
- Resistance Level
- EFSH $0.31
- ABVC $0.52
- Average True Range (ATR)
- EFSH 0.05
- ABVC 0.04
- MACD
- EFSH 0.73
- ABVC -0.00
- Stochastic Oscillator
- EFSH 35.23
- ABVC 25.56
About EFSH 1847 Holdings LLC
1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.